Untitled Document
 
Untitled Document click here to view Biomarkers-2012

pharma_menu

      Day1   Day2   Day3  

    OMICS Group’s 2nd World Congress on Biomarkers and Clinical Research 12-14 September 2011 Baltimore, Maryland, USA

    Theme: Strategies and Developments in Biomarkers & Clinical Research

    Date: 12-14 September 2011

    Venue: Baltimore, Maryland, USA

    Tel: Fax: Toll Free:
    +1-650-268-9744 +1-650-618-1414 +1-800-216-6499

    Website: https://www.omicsonline.org/biomarkers2011/

    Submit Your Abstract Online at
    https://www.omicsonline.org/ biomarkers2011/abstract.php

    We warmly invite you to attend and submit your abstract to 2nd World Congress on Biomarkers & Clinical Research.

    Biomarkers-2011 is comprised of 10 tracks and 44 sessions designed to offer comprehensive sessions that address current issues in Biomarkers & Clinical Research.

    Please submit your abstract to any of the following track.

    Track 1: Personalized Medicine & Data Analysis
    Track 1.1: Patient Segmentation and Stratification: Successful Integration of Diagnostic
                   Tools
    Track 1.2: Clinical Data Annotation: Classification Distribution Metrics, Pattern
                   Recognition
    Track 1.3: Genomic & Proteomic Strategies for Individualizing Therapy
    Track 1.4: Perspectives on Integrated Approach to Biomarkers
    Track 2: Biomarkers Classification & Molecular Sequence Analysis
    Track 2.1: Protein Biomarkers: Prognostic and C9 Protein Biomarkers
    Track 2.2: Emerging Biomarkers in Breast Cancer 
    Track 2.3: Biomarkers for Human Diseases
    Track 2.4: Blood Biomarkers: Serum Biomarkers & Blood Cells RNA Biomarkers
    Track 2.5: Cancer Biomarkers
    Track 2.6: DNA Methylation based Biomarkers and Bone Biomarkers
    Track 3: Biomarkers in Clinical Research & Development
    Track 3.1: Cancer Science & Therapy
    Track 3.2: Cardiovascular Diseases: Research & Therapy
    Track 3.3: Biomarkers in Endocrinology & Metabolism
    Track 3.4: Myeloid Leukemia: Biomarkers
    Track 3.5: Central Nervous System
    Track 3.6: Biomarkers for Multiple Sclerosis
    Track 4:Gene Expression Profiling and DNA Diagnostics
    Track 4.1: Transcription Profiling and Transcriptomic Analysis
    Track 4.2: DNA Diagnosis
    Track 4.3: Nutrient Arrays and Nano Wire Arrays
    Track 4.4: Clinical Array-based Karyotyping
    Track 5: OMICS Technologies in Biomarkers Discovery & Validation
    Track 5.1: Proteomics & Genomics
    Track 5.2: Molecular Informatics and Inflammation
    Track 5.3: Biomarkers: Toxicology
    Track 5.4: Glycomics & Lipidomics
    Track 6: Biomarkers in Drug Discovery
    Track 6.1: Biomarkers in Drug Discovery
    Track 6.2: Applications in New Drug Development
    Track 6.3: Translational Medicine
    Track 6.4: Clinical Trials, Pharmacokinetics and Pharmacodynamics
    Track 7: Enabling Technologies to Maximize Biomarker Identification
    Track 7.1: Mass Spectrometry and Spectroscopy
    Track 7.2: Microarray Technologies
    Track 7.3: Molecular Imaging and Dynamics
    Track 7.4: Statistics in Biomarker Research
    Track 8: Post Genomics: Drug and Biomarker Development
    Track 8.1: Drug Delivery & Safety
    Track 8.2: In Vitro Models for Drug Development  
    Track 8.3: Biomarkers for Drug Development
    Track 8.4: Biomarkers for Diagnosis
    Track 9: Clinical Research and Bioethics
    Track 9.1: Bioethics: Protection of Human Subjects
    Track 9.2: Ethical Regulatory Guidelines
    Track 9.3: Capacity Building in Clinical Research
    Track 9.4: Bioethics: Case Studies
    Track 10: Economic Considerations, Regulatory and Business of Biomarkers
    Track 10.1: Legal and Policy Issues with Biomarkers
    Track 10.2: Perspectives on Biomarkers and Personalized Medicine
    Track 10.3: Regulatory Guidelines
    Track 10.4: Future Business Strategies
    Participants List in Academia
    Untitled Document
    University of Texas at Arlington, USA

    Stanford University School of Medicine, USA

    Mahidol University, Thailand

    Amirkabir University of Technology, Iran

    Hamdard University, India

    Yeshiva University, USA

    University of Macau, China

    Monash University, Australia

    University of Michigan, Ann Arbor

    Universidade Federal do Rio de Janeiro, Brazil

    University of Denver, Colorado

    University of Toronto, Canada

    Zagazig University, Egypt

    Banaras Hindu University, India

    Taipei Medical University, Taiwan

    Università di Messina CNISM, Italy

    University of Tasmania, Australia

    Huazhong University of Science and Technology, China

    Sogang University, Korea

    University of Edinburgh, UK

    Martin-Luther-Universität Halle-Wittenberg, Halle/Saale

    Universidade de São Paulo, Brazil

    Eve University, Turkey

    University of Delhi, India

    Isfahan University of Technology(IUT), Iran

    Taif University, Saudi Arabia

    University Medical Center, Netherlands

    University of Copenhagen, Denmark

    Université Paris 13, France

    Participants List in Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Women’s Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddy’s labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria


    Operated By: Editors-Journal of Molecular Biomarkers & Diagnosis and Journal of Postgenomics: Drug & Biomarker Development
    Hosting Organization: OMICS Publishing Group